drugset / Trial / NCT00301262

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

NCT00301262 ↗

Phase 4 Completed 183 enrolled Viatris Inc. Pfizer · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Men's quality of life (QoL) is potentially affected by mild erectile dysfunction (ED) to the same extent as it is by moderate and severe ED. This study will provide controlled clinical data measuring efficacy, QoL parameters and satisfaction changes in men with mild ED treated with Viagra versus those treated with a placebo. With an open-label extension, this study will also provide all study subjects the opportunity to receive the active drug treatment for 6 weeks.

Timeline

Start
2005-11
Primary completion
2007-09
Completion
2007-09

Outcome

Met primary endpoint

registry analysis (unspecified test); DB Viagra vs DB Placebo; p <0.0001; Mean Difference (Final Values) 18.13 (95% CI 11.40 to 24.86); ANCOVA; NCT00301262 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg —
Subject Sildenafil Unknown 50 mg —
Subject Sildenafil Unknown 100 mg —

Indications